Dr, Department of Medicines and Medical Devices Authority, Muhimbili University of Health and Allied Sciences, Dares Salaam, Tanzania
Review Article
Quality Surveillance of Anti-Tuberculosis Medicines in Tanzania, 2012-2018
Author(s): Kissa W. Mwamwitwa*, Betty A. Maganda, Seth Kisenge, Sophia A. Mziray, Henry Irunde, Yonah H. Mwalwisi, Adam M. Fimbo, Wilbroad Kalala, Adelard Mtenga, Akida M. Khea, Adonis Bitegeko, Danstan H. Shewiyo, Eliangiringa Kaale and Blandina T. Mbaga
Background: The use of substandard and falsified (SF) anti-tuberculosis (ant-TB) medicines may lead to treatment
failure and development of drug resistance. SF medicinal products are claimed to be more prevalent in developing
countries with high burden of tuberculosis disease. National Regulatory Authorities therefore, should ensure that the
quality of these life-saving medicines is systematically monitored. We conducted a post marketing surveillance study
to determine the quality of anti-tuberculosis medicines circulating on the market in Tanzania Mainland.
Methods: This was a prospective cross sectional study conducted between 2012 and 2018. Purposive sampling
technique was used in collecting a total of 777 samples of anti-tuberculosis medicines. Samples were collected from
ports of entry, Medical Stores Depar.. View more»